Beyond the Label: A Patient-Centred Approach to Polycystic Ovary Syndrome

Authors

  • Lara Briden Centre for Menstrual Cycle and Ovulation Research (CeMCOR), University of British Columbia, Vancouver, BC, Canada.

DOI:

https://doi.org/10.54434/candj.114

Keywords:

Overdiagnosis, neuroendocrine, hyperandrogenism, oral micronized progesterone

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age. Importantly, it is not one disease with a single pathophysiology but is instead a heterogeneous syndrome with several underlying biological mechanisms. Careful diagnosis requires attention to the key symptom of androgen excess as well as the exclusion of similar disorders including hyperprolactinemia, late-onset congenital adrenal hyperplasia, and hypothalamic amenorrhea. A patient-centred approach to treatment requires further assessment of underlying drivers and mechanisms including neuroendocrine disturbance, insulin resistance, and adrenal hyperresponsiveness.

Downloads

Download data is not yet available.

Published

2022-06-28

How to Cite

1.
Briden L. Beyond the Label: A Patient-Centred Approach to Polycystic Ovary Syndrome. CANDJ [Internet]. 2022 Jun. 28 [cited 2022 Aug. 17];29(2):2-8. Available from: https://candjournal.ca/index.php/candj/article/view/114

Issue

Section

Perspective(s)

Categories